Abstract:Chronic graft-versus-host disease (cGVHD) is one of the main complications of transplantation in allogeneic hematopoietic cells which results in reduced quality of life. cGVHD mostly affects the oral cavity, producing various symptoms and manifestations. It can lead to both short- and long-term complications such as limited oral intake, mucosal sensitivity, secondary malignancy and even early death. GVHD is an alloimmune and autoimmune disorder with a variable clinical course that commonly involves various tissues and organs. It can occur in both the acute and chronic forms. In the case of cGVHD, a large number of organs are affected including the oral cavity. However, in some cases of cGVHD only the oral cavity gets affected. The clinical indications of chronic oral GVHD may include sclerosis, hyperkeratotic plaques, lichenoid lesions, and limited oral aperture. The level of oral involvement is commonly mild, but medium to high severity erosive as well as ulcerated lesions may also be occurred. Although diagnosed through clinical examination, its confirmation is usually done by biopsy study. The first treatment option is using local corticosteroids with the potency to treat half of patients. Extracorporeal photopheresis and systemic corticosteroids are in the next ranks. Patient survival after diagnosis of oral chronic GVHD is within 4.5 years in 50% of the cases, thus it is not regarded as a determinant factor in patient survival. This study attempted to provide a detailed approach for clinical diagnosis and management of patients suffered from oral cGVHD. It is particularly considered the factors such as differential diagnosis, symptom control, screening for and prevention of secondary complications. It has been tried to provide practical and relevant considerations and recommendations for all clinicians who dealswith oral cGVHD patients in order to achieve improved care and outcomes.

Clinical manifestation and treatment of graft versus host disease in oral cavity

Multiple Oral Manifestations in a Patient With Chronic Graft Versus Host Disease: A Case Report

A Review on Therapeutic Management for Oral Chronic Graft-versus-Host Disease

Pathogenesis, Diagnosis, Current Treatment, and Emerging Therapies

Oral Manifestations Of Graft-Versus-Host Disease: Report Of Two Cases.

Oral Chronic Graft-versus-Host Disease and Oral Health after Allogeneic Hematopoietic Cell Transplantation - What the Care Team Needs to Know

Oral Submucous Fibrosis Induced by Graft-Versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

A Primary Analysis of Oral Mucosa and Periodontal Status of Chronic Graft-Versus-host Disease Caused by Hematopoietic Stem Cell Transplantation

Oral Graft-Versus-Host Disease In Stem Cell Transplantation: Case Report.

Graft-Versus-Host Disease: Challenges For Diagnosis And Treatment.

Prevalence of oral chronic graft versus host disease after allogeneic stem cell transplantation

Oral manifestations of graft-versus-host disease in patients submitted to allogeneic hematopoietic stem cell transplantation: the experience of a Brazilian Cancer Center

[Latest Research Progress on Pathogenesis of Chronic Graft Versus Host Disease and Its Related Problems].

Oral squamous cell carcinoma arising from areas of Graft-versus-host disease: A systematic review

Clinical Analysis on Graft-Versus-host Disease in 55 Cases of Allogeneic Hematopoietic Stem Cell Transplantation

The Role of Intestinal Microbiota in Acute Graft-versus-Host Disease

Orchestrating Oral Chronic Graft-Versus-Host Disease: The Tryptophan Connection

[Pathogenesis and Therapeutic Prospects of Chronic Graft-Versus-Host Disease --Review]

Acute graft-vs-host disease: pathobiology and management

Early intervention with oral mucosal barrier Protective agents in chronic oral graft-versus-host disease: a retrospective cohort study

Interplay Between the Intestinal Microbiota and Acute Graft-Versus-Host Disease: Experimental Evidence and Clinical Significance